From Tik­Tok to the Os­cars: How mar­ket­ing obe­si­ty drugs is no longer just the purview of Eli Lil­ly and No­vo Nordisk

Obe­si­ty drugs have a brand­ing prob­lem.

Thanks to Tik­Tok, Hol­ly­wood gos­sip and ea­ger med­ical spas and clin­i­cians, few peo­ple both­er to dis­tin­guish the names and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER